These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 10235368)
1. Expression of p16 and CDK4 in oral premalignant lesions and oral squamous cell carcinomas: a semi-quantitative immunohistochemical study. Chen Q; Luo G; Li B; Samaranayake LP J Oral Pathol Med; 1999 Apr; 28(4):158-64. PubMed ID: 10235368 [TBL] [Abstract][Full Text] [Related]
2. [Expression of CDK4 protein in oral carcinogenesis]. Chen Q; Luo G; Li B; He Z; Chen L; Cao X; Nie M Hua Xi Kou Qiang Yi Xue Za Zhi; 1999 Feb; 17(1):8-10. PubMed ID: 12539309 [TBL] [Abstract][Full Text] [Related]
3. [Bax protein expression in the carcinogenesis of human oral mucosa]. Zeng X; Chen Q; Li B; Tan N Hua Xi Kou Qiang Yi Xue Za Zhi; 2000 Apr; 18(2):88-90. PubMed ID: 12539337 [TBL] [Abstract][Full Text] [Related]
4. Analysis of a role for p16/CDKN2 expression and methylation patterns in human oral squamous cell carcinoma. Yakushiji T; Noma H; Shibahara T; Arai K; Yamamoto N; Tanaka C; Uzawa K; Tanzawa H Bull Tokyo Dent Coll; 2001 Aug; 42(3):159-68. PubMed ID: 11806150 [TBL] [Abstract][Full Text] [Related]
5. Assessment of c-Jun, c-Fos and cyclin D1 in premalignant and malignant oral lesions. Turatti E; da Costa Neves A; de Magalhães MH; de Sousa SO J Oral Sci; 2005 Jun; 47(2):71-6. PubMed ID: 16050486 [TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical analysis of cell cycle-associated proteins p16, pRb, p53, p27 and Ki-67 in oral cancer and precancer with special reference to verrucous carcinomas. Saito T; Nakajima T; Mogi K J Oral Pathol Med; 1999 May; 28(5):226-32. PubMed ID: 10226946 [TBL] [Abstract][Full Text] [Related]
7. pRb and p16 protein alterations in human oral tumorigenesis. Pande P; Mathur M; Shukla NK; Ralhan R Oral Oncol; 1998 Sep; 34(5):396-403. PubMed ID: 9861348 [TBL] [Abstract][Full Text] [Related]
8. Alteration in the expression of cdk4 and cdk6 proteins in oral cancer and premalignant lesions. Poomsawat S; Buajeeb W; Khovidhunkit SO; Punyasingh J J Oral Pathol Med; 2010 Nov; 39(10):793-9. PubMed ID: 20618617 [TBL] [Abstract][Full Text] [Related]
9. Inverse expression of Cdk4 and p16 in epithelial ovarian tumors. Sui L; Dong Y; Ohno M; Goto M; Inohara T; Sugimoto K; Tai Y; Hando T; Tokuda M Gynecol Oncol; 2000 Nov; 79(2):230-7. PubMed ID: 11063650 [TBL] [Abstract][Full Text] [Related]
10. Alterations of rb pathway components are frequent events in patients with oral epithelial dysplasia and predict clinical outcome in patients with squamous cell carcinoma. Soni S; Kaur J; Kumar A; Chakravarti N; Mathur M; Bahadur S; Shukla NK; Deo SV; Ralhan R Oncology; 2005; 68(4-6):314-25. PubMed ID: 16020958 [TBL] [Abstract][Full Text] [Related]
11. Expression of p16 and cyclin-dependent kinase 4 proteins in primary breast carcinomas. Ito Y; Kobayashi T; Takeda T; Nakano Y; Tamaki Y; Komoike Y; Wakasugi E; Shin E; Takatsuka Y; Kikkawa N; Matsuura N; Monden M Oncology; 1997; 54(6):508-15. PubMed ID: 9394849 [TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical expression of p53, p16 and hTERT in oral squamous cell carcinoma and potentially malignant disorders. Abrahao AC; Bonelli BV; Nunes FD; Dias EP; Cabral MG Braz Oral Res; 2011; 25(1):34-41. PubMed ID: 21359449 [TBL] [Abstract][Full Text] [Related]
13. p16INK4A in oral squamous cell carcinomas--a correlation with biological behaviors: immunohistochemical and FISH analysis. Suzuki H; Sugimura H; Hashimoto K J Oral Maxillofac Surg; 2006 Nov; 64(11):1617-23. PubMed ID: 17052587 [TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of p16 and CDK4 proteins in localized prostate carcinoma. Halvorsen OJ; Høstmark J; Haukaas S; Høisaeter PA; Akslen LA Cancer; 2000 Jan; 88(2):416-24. PubMed ID: 10640976 [TBL] [Abstract][Full Text] [Related]
15. Cyclin D1 expression and its possible regulation in chewing tobacco mediated oral squamous cell carcinoma progression. Mishra R; Das BR Arch Oral Biol; 2009 Oct; 54(10):917-23. PubMed ID: 19679297 [TBL] [Abstract][Full Text] [Related]
16. Role of p16/MTS1, cyclin D1 and RB in primary oral cancer and oral cancer cell lines. Sartor M; Steingrimsdottir H; Elamin F; Gäken J; Warnakulasuriya S; Partridge M; Thakker N; Johnson NW; Tavassoli M Br J Cancer; 1999 Apr; 80(1-2):79-86. PubMed ID: 10389982 [TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical characterization of cyclin dependent kinase-4 in different histological grades of oral leukoplakia and oral squamous cell carcinoma. Shyam N; Rao NN; Narang RD; George J; Bommu SR; Kiran G J Oral Maxillofac Pathol; 2014 Jan; 18(1):36-41. PubMed ID: 24959035 [TBL] [Abstract][Full Text] [Related]
18. Altered expression of cell cycle regulators Cyclin D1, p14, p16, CDK4 and Rb in nodular melanomas. Bachmann IM; Straume O; Akslen LA Int J Oncol; 2004 Dec; 25(6):1559-65. PubMed ID: 15547691 [TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical analysis of the expression of cdk4 and p16INK4 in human endometrioid-type endometrial carcinoma. Shiozawa T; Nikaido T; Shimizu M; Zhai Y; Fujii S Cancer; 1997 Dec; 80(12):2250-6. PubMed ID: 9404701 [TBL] [Abstract][Full Text] [Related]
20. Altered mRNA expression of the Rb and p16 tumor suppressor genes and of CDK4 in transitional cell carcinomas of the urinary bladder associated with tumor progression. Quentin T; Henke C; Korabiowska M; Schlott T; Zimmerman B; Kunze E Anticancer Res; 2004; 24(2B):1011-23. PubMed ID: 15161057 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]